The Central Drugs Standard Control Organization (CDSCO) has issued an advisory to pharmaceutical manufacturers, importers, and marketing authorization holders to ensure strict compliance with the provisions of the Drugs and Cosmetics Act, 1940 and Rules, 1945 in the promotion and marketin
Mumbai (Maharashtra) [India], December 2: ImmunoAdoptive Cell Therapy (ImmunoACT), the Mumbai, India-based pioneering research and cell and gene therapy development company, announced a strategic partnership with Mango Sciences, Inc., the Boston, US, and Bengaluru, IN-based data and AI compa
In a study published November 5 in Nature, the team found that microglia with lower levels of a transcription factor called PU.1 and higher expression of a receptor known as CD28 help reduce brain inflammation.
In a statement provided to ANI, Novo Nordisk has stated that Ozempic is intended for individuals with Type 2 diabetes and will be available only upon a doctor's prescription.
Pennington (New Jersey) [US] / Ahmedabad (Gujarat) [India], August 30: Zydus Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., a global innovation led healthcare company, today announced positive topline results from the pivotal EPICS-III Phase 2(b)/3 clinical trial. In
According to an official statement from Eli Lilly and Company, "Orforglipron is the first oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water restrictions, to successfully complete a Phase 3 trial."
The VMMC and Safdarjung Hospital has successfully performed its first-ever Chimeric Antigen Receptor T-cell (CAR-T) therapy under the leadership of Prof. Sandeep Bansal (Medical Superintendent), a novel treatment for certain types of lymphoma and blood cancers.
Singapore, October 5: A new cell therapy, targeting CD7 on leukaemia cells, gives a potentially effective treatment for patients with T-cell acute lymphoblastic leukaemia (T-ALL) who have exhausted all standard treatment options. Published in the prestigious medical journal Nature Medicine o
The protein receptor Tyrosine phosphatases are proteins that are found in cell membranes. Although the details of their exact mechanism of action remain unknown, they are known to be tumour suppressors and regulators of cell-cell interactions.
Macrophages are essential to the immune system because they combat infections and help heal damaged tissue. It's critical to comprehend how these cells are triggered in various contexts in order to design novel medical interventions. The complexity of these cells and their reactions has made
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been shown in the SELECT Trial to be effective in preventing the loss of kidney function in people who are overweight or obese and have established cardiovascular disease but do not have diabetes